Can You Get Peptides Prescribed Online? How Telehealth Prescribing Works, State by State

Key takeaways

Yes, peptides can be prescribed online, legally, when three things line up: the compound is an FDA-approved drug or one a licensed pharmacy may compound, the clinician is licensed in the state where you are during the visit, and the visit meets that state's standard for starting a patient relationship.
In October 2026 the prescribable list is semaglutide and tirzepatide (brand, or compounded only for a documented individual need), tesamorelin (brand Egrifta only), sermorelin, bremelanotide (PT-141), glutathione and NAD+. BPC-157, TB-500, CJC-1295, ipamorelin and MOTS-c cannot be filled by any pharmacy, online or in person.
Peptides are not controlled substances, so the Ryan Haight Act's in-person rule does not apply to them. Testosterone, often sold alongside, is Schedule III; the DEA rules that let it be prescribed after a live video visit run through December 31, 2026.
Whether a questionnaire is enough is a state decision. Eleven of the fourteen jurisdictions we verified bar questionnaire-only prescribing or name a real-time visit as the way to start; California, Florida and Missouri allow asynchronous evaluation under conditions.
The pharmacy must be licensed where you live too. Florida, for example, requires an out-of-state pharmacy shipping compounded injectables into the state to hold a separate nonresident sterile compounding permit.

Yes. A licensed clinician can prescribe peptides through a telehealth visit and a licensed pharmacy can ship them to you, as long as the peptide is one a pharmacy can legally supply and the visit follows the rules of the state you are in. Which compounds pass that test is set out compound by compound in can telehealth prescribe peptides; whether you are a candidate for one is answered in who qualifies for peptide therapy. This page explains the machinery in between: licensure, the interstate compact, the controlled-substance exception, state rules on live visits, pharmacy licensing and what a legitimate visit looks like.

Which peptides can be prescribed online, and which cannot

A telehealth prescription is an ordinary prescription. If a pharmacy may fill it after an office visit, it may fill it after a telehealth visit that meets the state's standard; if no pharmacy may fill it, a video call does not change that. So the first question is the status of the compound, which our legal tracker follows.

Compound	Can a telehealth clinician prescribe it? (October 2026)	Why
Semaglutide (Wegovy, Ozempic)	Yes for the brand; compounded only for a documented individual need	FDA-approved; shortage declared resolved February 21, 2025
Tirzepatide (Zepbound, Mounjaro)	Yes for the brand; compounded only for a documented individual need	FDA-approved; shortage declared resolved December 19, 2024
Tesamorelin	Yes, brand only (Egrifta WR, or Egrifta SV where still supplied)	FDA-approved, but regulated as a biological product, so it cannot be compounded
Sermorelin	Yes, compounded	Component of a formerly approved drug (Geref)
Bremelanotide (PT-141)	Yes, brand (Vyleesi) or compounded, within the 'essentially a copy' limit	Component of an approved drug
Glutathione	Yes, compounded	Category 1 (interim policy)
NAD+ (not a peptide, sold alongside)	Yes, compounded, under FDA's interim policy	In Category 1 while FDA's evaluation is pending
BPC-157, TB-500, KPV, MOTS-c, epitalon, semax	No	Recommended by FDA's advisory committee in July 2026; not permitted until FDA completes rulemaking
CJC-1295, ipamorelin, AOD-9604, thymosin alpha-1, kisspeptin-10	No	Voted down by the advisory committee in 2024
GHK-Cu, topical	Yes, compounded, under FDA's interim policy	Category 1 (interim policy) since May 2026; review due by February 2027; cosmetic creams are a different category
GHK-Cu, injectable	No	Off Category 2 since April 2026 (nomination withdrawn); not in Category 1 or on the bulks list; review due by February 2027
Retatrutide	No	Investigational
Human growth hormone for anti-aging	No	Distribution for unapproved uses is a federal crime under 21 U.S.C. 333(e)
Testosterone (not a peptide)	Yes, under controlled-substance rules	Schedule III; see below

The 'No' rows are not a telehealth restriction. A pharmacy may compound a bulk substance only if it has a USP monograph, is a component of an FDA-approved drug or appears on FDA's 503A bulks list (FDA 503A list), and BPC-157 and the rest pass none of those tests. The July 2026 committee votes were recommendations made over the objection of FDA's own reviewers, who cited missing human data (HPM 2026a). Until a final rule appears, a 'prescription' for those compounds has no pharmacy that can lawfully fill it.

How telehealth prescribing works legally

Four layers of law apply to every online prescription: federal drug law (FDA) decides what may be prescribed and compounded; federal controlled-substance law (DEA) adds rules for scheduled drugs; state medical, nursing and physician assistant boards decide who may treat a patient in their state and what counts as an adequate evaluation; and state pharmacy boards decide which pharmacies may dispense to residents.

The license must match where you are

Telehealth is treated as happening at the patient's physical location, so the clinician typically needs a license in the patient's state, with narrow exceptions in a few states (CCHP licensing). Oregon's statute puts it plainly: the practice of medicine using telemedicine occurs where the patient is physically located (CCHP online prescribing).

Consequences: a clinician in Texas treating you while you are in Colorado needs a Colorado license. If you open the app from a hotel in another state, that state's rules apply, which is why intakes ask where you are right now and why Alabama's medical board requires the physician to have the patient state their city and state before a telehealth visit (CCHP online prescribing). And a company that 'serves all 50 states' is a network of clinicians with different licenses, so the one who signs your prescription should be named and licensed in your state. Nurse practitioners and physician assistants can prescribe the same compounds where their state's scope rules allow it, licensed state by state through their own boards. There is no national prescribing license.

The Interstate Medical Licensure Compact

The compact is how one physician ends up licensed in many states. A physician with a full, unrestricted license in a home state applies once, receives a letter of qualification, and then gets a separate license from each member state chosen; the commission is explicit that licensing stays state-based and there is no 'compact license' (IMLCC). As of its September 30, 2026 snapshot, the compact included 44 states, the District of Columbia and Guam. Four member states (Alaska, Arkansas, New Mexico and Rhode Island) were still implementing it, with Arkansas due to start processing compact applications on October 12, 2026 (IMLCC). The compact covers physicians only, and it changes nothing about verification: the license that matters is the one your state's board issued, and you can look it up there.

Controlled substances: the Ryan Haight Act, and why testosterone is different

The Ryan Haight Act of 2008 bars dispensing a controlled substance by means of the internet without a valid prescription, defined as one from a practitioner who has conducted at least one in-person medical evaluation, or a covering practitioner (21 U.S.C. 829(e)). No peptide in the table is a scheduled drug, so this rule does not touch them.

Testosterone is scheduled: it is listed among the anabolic steroids in Schedule III (21 CFR 1308.13), and men shopping for peptides online are often offered it in the same cart. Since 2020, temporary DEA flexibilities, extended by rule since 2023, have let DEA-registered practitioners prescribe Schedule II to V drugs after an audio-video telemedicine visit without a prior in-person evaluation; the fourth extension runs through December 31, 2026 (DEA, 90 FR 61301). DEA sent a final telemedicine 'special registration' rule to the White House regulatory office on August 25, 2026, with its text not yet public in mid-September (McDermott 2026). If neither a new rule nor another extension takes effect, the in-person requirement returns for new telehealth relationships on January 1, 2027.

Testosterone cannot be prescribed from a questionnaire. Even under the flexibilities, the encounter must be live audio-video.
States can be stricter. As summarized by the Center for Connected Health Policy, Arkansas' medical board bars a physician using telemedicine from prescribing any Schedule II to V drug without an in-person exam or another listed relationship, and Alabama's board allows a controlled substance by telehealth only after a live audio or video visit and an in-person encounter within the preceding 12 months (CCHP online prescribing).
The clinical standard still applies. The Endocrine Society guideline diagnoses low testosterone from two fasting morning measurements and monitors testosterone and hematocrit after starting (Bhasin 2018). A program that skips the labs skips the diagnosis.

Human growth hormone is a separate case: not scheduled, but distributing it for anything other than an FDA-recognized disease is a federal crime, which is why anti-aging programs prescribe sermorelin or tesamorelin instead.

Synchronous versus asynchronous visits, state by state

A synchronous visit is live: video, or in some states a phone call. An asynchronous visit is a questionnaire, sometimes with photos or records, that a clinician reviews later and follows with messaging. Because peptides are not controlled substances, federal law does not require a live visit; state law decides. The Center for Connected Health Policy, which tracks these rules, summarizes the national picture: most states consider an online questionnaire alone inadequate to establish the relationship a prescription requires, while not all states require an in-person exam and some explicitly allow it by telehealth (CCHP online prescribing).

We checked fourteen jurisdictions against CCHP's state summaries in October 2026 and read North Dakota's statute in the official code. The table covers only those fourteen.

State	What the rule says about starting care by telehealth	Citation (as summarized by CCHP)
Arkansas	Requires an in-person exam, a real-time audio and video exam, or an existing relationship; an internet questionnaire, email or text cannot establish one	Ark. Code 17-80-402 and 403; Medical Board Rule 2.8
District of Columbia	Without a prior in-person interaction, the physician may use real-time telemedicine to establish the relationship	17 DCMR 4618
Kansas	For dispensing, a legitimate medical purpose means a preexisting relationship, not one established through an internet questionnaire	K.A.R. 68-2-20
Kentucky	A questionnaire evaluation, online or by phone, is inadequate for the initial or any follow-up evaluation	KRS 311.597
Mississippi	Store-and-forward may enhance but never replace real-time interaction (video, or audio only where appropriate); a simple questionnaire violates board policy	Miss. Admin. Code Title 30, Part 2635, Rule 5
New Mexico	Prescribing based solely on an online questionnaire is unprofessional conduct, except in a face-to-face videoconference encounter	16.10.8.8 NMAC
North Dakota	A static online questionnaire or an audio conversation alone does not meet the standard of care; secure video, or store-and-forward with appropriate testing, can	N.D. Cent. Code 43-17-44 (official text)
Rhode Island	Questionnaire-only prescribing is unprofessional conduct; asynchronous evaluation without a real-time exchange is not appropriate	216-RICR-40-05-1
South Dakota	Real-time audio and video exam required before diagnosis and treatment when a face-to-face encounter would otherwise be required	SDCL 34-52-5
Texas	Synchronous audio-video, or store-and-forward plus live audio using clinical information such as images or records	Tex. Occ. Code 111.005
West Virginia	Email, internet questionnaires and texts cannot establish the relationship; real-time video or real-time audio-only can	W. Va. Code 30-3-13a and 30-14-12d
California	An appropriate prior exam does not require a synchronous interaction and may use a questionnaire, if the standard of care is met	Cal. Bus. and Prof. Code 2242(a)
Florida	A telehealth evaluation sufficient to diagnose and treat is enough; no separate physical exam required	Fla. Stat. 456.47
Missouri	A questionnaire may establish the relationship if it gives information as though in person, the treating clinician reviews it, the provider works for an entity licensed in Missouri, and a report goes to the primary-care provider within 14 days	Mo. Rev. Stat. 191.1146, as amended in 2026

All other states vary, and the rules change every legislative session; check CCHP's tracker for yours (CCHP online prescribing). Two cautions. First, a provider's policy may be stricter than the law: PepScribe, in our clinic directory, requires a brief live visit in Arkansas, Kansas, Mississippi, Missouri, New Mexico, North Dakota, Oregon, West Virginia and the District of Columbia, including Missouri, where a questionnaire is allowed under conditions, and Oregon, where CCHP's summary shows no explicit live-visit rule. Second, a state that allows asynchronous care still holds the clinician to the in-person standard of care. Whatever your state allows, a GLP-1 drug or a growth hormone secretagogue deserves at least one live conversation and a lab review.

The pharmacy: licenses and shipping across state lines

The pharmacy needs a license or registration in every state it ships to. Florida is a clear example. A pharmacy outside Florida that ships a dispensed drug into the state must register as a nonresident pharmacy, hold a valid home-state license and print a toll-free number on each label that reaches a pharmacist with the patient's records. To ship a compounded sterile product, which includes every compounded peptide injection, it must also hold a nonresident sterile compounding permit, attest that its products meet Florida's sterile compounding standards, and submit its USP 797 procedures and a current inspection report (Florida 465.0156 and 465.0158).

Other states add layers. Arkansas requires an out-of-state or mail-order pharmacy filling a first prescription for a new patient to establish a pharmacist-patient relationship by phone or telemedicine (CCHP online prescribing). The pharmacy boards' national association accredits online pharmacies only if they hold active licenses in every jurisdiction where they do business (NABP). Rules like these are the usual reason a compound is 'not available in your state', and why Henry Meds, in our directory, tells California patients their orders take longer because of compound testing requirements.

Most telehealth peptide prescriptions are filled by state-licensed 503A pharmacies compounding for a named patient; 503B outsourcing facilities register with FDA and make batches. The better providers name theirs: in our October 2026 directory, PepScribe names MediVera Compounding Pharmacy in Troy, Michigan, and System Labs names The Pharmacy Hub in Miami, while the other ten did not name a pharmacy on their websites. The label should come from the pharmacy, with the concentration and a beyond-use date. With vials and syringes, ask how the dose is written: a poison-center case series described patients who took ten times the intended dose of compounded semaglutide after dosing in milliliters or syringe units instead of milligrams (Lambson 2023). Our units guide and peptide calculator do the conversion.

What a legitimate online visit includes

Location and identity, because the prescriber must be licensed in the state you are in.
A history that looks for reasons to say no: cancer, a personal or family history of medullary thyroid cancer or MEN 2 before a GLP-1, blood pressure and heart disease before bremelanotide, diabetes and pituitary history before a growth hormone secretagogue, pregnancy plans and every current medicine. Our qualification guide lists them by compound.
A named clinician with a credential (MD, DO, NP or PA) and a license in your state, reviewing your case live where the state requires it.
Labs when the compound calls for them: A1c and kidney function before a GLP-1, IGF-1 and glucose before sermorelin or tesamorelin, two morning testosterone levels before testosterone. The complete guide has the labs-by-goal table.
A readable prescription: dose in milligrams or micrograms, vial concentration, syringe units and frequency; brand by default for GLP-1s, with the patient-specific reason written down for any compounded version.
A named pharmacy licensed in your state, before you pay.
A follow-up date and a stop rule, plus a way to reach a clinician about side effects.

For GLP-1 drugs specifically, our guide to getting tirzepatide online walks through the same checks.

Red flags

A non-compoundable peptide sold as a prescription: BPC-157, TB-500, CJC-1295, ipamorelin, MOTS-c, AOD-9604, epitalon. Three of the twelve providers in our directory list such compounds, and a fourth names one as an example.
No live visit where the state requires one, or testosterone without a live video visit.
No clinician name or license, or a prescriber not licensed in your state; check your state's medical, nursing or physician assistant board.
No pharmacy named, or the telehealth brand's name on the vial.
Approval in minutes for everyone, and no labs before a GLP-1 or growth hormone secretagogue.
'FDA-approved' language for a compounded product, the claim FDA's 2026 warning letters targeted; the legal tracker has the dates.

What it costs

October 9, 2026 figures from our cost guide and directory:

Item	Typical cost
Telehealth peptide program, medication included	$150 to $450 a month
Sermorelin at the providers in our directory	$153 to $233 a month
NAD+ injections at the providers in our directory	$149 to $189 a month
First consultation	$0 to $200
Baseline labs	$100 to $400
Zepbound through Lilly's self-pay program	$299 to $449 a month
Wegovy through NovoCare	$349 a month

Compounded peptides are cash-pay; prescriptions and the visits that produce them usually qualify for HSA and FSA money. First-month discounts of $50 to $110 are common, so compare the total for three months, including memberships and dose increases.

Bottom line

Getting peptides prescribed online is legal and routine when the compound can be legally supplied, the clinician is licensed where you are, the visit meets your state's standard and a licensed pharmacy ships the drug. For non-controlled drugs the states set the visit format, and most of those we checked want a live interaction or forbid questionnaire-only prescribing. Testosterone rides on DEA rules that expire December 31, 2026. None of this machinery makes BPC-157, TB-500 or the other non-compoundable peptides prescribable, and a clinic that says otherwise is telling you how to read everything else it says.

Frequently asked questions

+Can you get prescribed peptides online?

Yes, if the peptide is an FDA-approved drug or one a licensed pharmacy may legally compound, the clinician holds a license in the state where you are during the visit, and the visit meets that state's standard for starting a patient relationship. In October 2026 that covers semaglutide and tirzepatide (brand, or compounded only for a documented individual need), tesamorelin (brand Egrifta only), sermorelin, bremelanotide (PT-141), glutathione and NAD+. It does not cover BPC-157, TB-500, CJC-1295, ipamorelin or MOTS-c, which no pharmacy may compound.

+Who can prescribe peptides?

Any licensed clinician with prescribing authority in your state: physicians (MD or DO), and nurse practitioners and physician assistants within their state's scope-of-practice rules. There is no peptide specialty or certification. What limits the prescription is the drug, not the prescriber: no clinician can make a non-compoundable peptide legal by writing it on a prescription pad.

+How do I get peptides prescribed?

Pick the compound first, using the legal tracker, then see a clinician licensed in your state, in person or by telehealth. Expect a history covering cancer, thyroid cancer in the family, blood pressure, pregnancy plans and current medicines, and labs for GLP-1 drugs and growth hormone secretagogues. If you qualify, the prescription goes to a named, licensed pharmacy that ships to your state, and a follow-up date should be set before the first dose.

+Can I get a BPC-157 prescription online?

Not one a pharmacy can legally fill. As of October 2026 BPC-157 is not FDA-approved, is not on FDA's list of bulk substances that 503A pharmacies may use and has no USP monograph. FDA's advisory committee voted 8 to 6 in July 2026 to recommend adding it, but FDA has not completed rulemaking. A website that pairs a consultation with BPC-157 is selling a research vial with paperwork attached.

+How to legally buy peptides?

With a prescription from a licensed clinician, filled by a pharmacy licensed in your state: a retail or mail-order pharmacy for brand products such as Wegovy, Zepbound, Egrifta WR or Vyleesi, or a state-licensed compounding pharmacy for sermorelin, bremelanotide, glutathione or NAD+. Tesamorelin is filled only as the brand, because it is a biological product that no pharmacy may compound. Vials sold without a prescription under a research-use label are unapproved drugs when marketed for human use, as FDA's 2026 warning letters stated.

+Can peptides be shipped?

Yes. Prescribed peptides ship cold from the pharmacy to your address, usually within a week of approval. The pharmacy must be licensed or registered in the state it ships to, and some states add rules for compounded sterile products, which is the usual reason a provider says a compound is not available in your state.

+Can I get a testosterone prescription online?

Yes in 2026, with conditions. Testosterone is a Schedule III controlled substance, so the Ryan Haight Act normally requires at least one in-person evaluation before it is prescribed remotely. Temporary DEA rules let DEA-registered clinicians prescribe it after a live audio-video visit through December 31, 2026, and some states are stricter. A questionnaire-only testosterone prescription is not legal.

+How much do peptide treatments cost?

Most telehealth peptide programs charged $150 to $450 a month with the medication included in October 2026, plus $0 to $200 for a first consultation and $100 to $400 for labs. Sermorelin ran $153 to $233 a month at the providers in our directory. Brand Zepbound costs $299 to $449 a month through Lilly's self-pay program. Compounded peptides are cash-pay.

+Can I talk to a doctor about peptides?

Yes, and you should before buying anything. Any primary-care physician, endocrinologist or telehealth clinician licensed in your state can discuss which peptides have evidence for your goal, which ones can be legally prescribed and what labs make sense. A clinician who refuses to discuss contraindications or the pharmacy is not giving you a consultation.